Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Defining Virus-specific CD8+ TCR Repertoires for Therapeutic Regeneration of T Cells against Chronic Hepatitis E.

Soon CF, Behrendt P, Todt D, Manns MP, Wedemeyer H, Chen MS, Cornberg M.

J Hepatol. 2019 Jun 13. pii: S0168-8278(19)30349-6. doi: 10.1016/j.jhep.2019.06.005. [Epub ahead of print]

PMID:
31203151
2.

Hepatitis E Virus Drug Development.

Kinast V, Burkard TL, Todt D, Steinmann E.

Viruses. 2019 May 28;11(6). pii: E485. doi: 10.3390/v11060485. Review.

3.

Equine Parvovirus-Hepatitis Frequently Detectable in Commercial Equine Serum Pools.

Meister TL, Tegtmeyer B, Postel A, Cavalleri JV, Todt D, Stang A, Steinmann E.

Viruses. 2019 May 21;11(5). pii: E461. doi: 10.3390/v11050461.

4.

Influence of Tattoo Ink on Hepatitis C Virus Infectiousness.

Behrendt P, Brüning J, Todt D, Steinmann E.

Open Forum Infect Dis. 2019 Feb 13;6(3):ofz047. doi: 10.1093/ofid/ofz047. eCollection 2019 Mar.

5.

A central hydrophobic E1 region controls the pH range of hepatitis C virus membrane fusion and susceptibility to fusion inhibitors.

Banda DH, Perin PM, Brown RJP, Todt D, Solodenko W, Hoffmeyer P, Kumar Sahu K, Houghton M, Meuleman P, Müller R, Kirschning A, Pietschmann T.

J Hepatol. 2019 Jun;70(6):1082-1092. doi: 10.1016/j.jhep.2019.01.033. Epub 2019 Feb 13.

PMID:
30769006
6.

Cell culture systems for the study of hepatitis E virus.

Meister TL, Bruening J, Todt D, Steinmann E.

Antiviral Res. 2019 Mar;163:34-49. doi: 10.1016/j.antiviral.2019.01.007. Epub 2019 Jan 14. Review.

7.

SEC14L2, a lipid-binding protein, regulates HCV replication in culture with inter- and intra-genotype variations.

Costa R, Todt D, Zapatero-Belinchón F, Schenk C, Anastasiou OE, Walker A, Hertel B, Timmer L, Bojkova D, Ruckert M, Sarrazin C, Timm J, Lohmann V, Manns MP, Steinmann E, von Hahn T, Ciesek S.

J Hepatol. 2019 Apr;70(4):603-614. doi: 10.1016/j.jhep.2018.11.012. Epub 2018 Nov 23.

PMID:
30472319
8.

Functional and immunogenic characterization of diverse HCV glycoprotein E2 variants.

Khera T, Behrendt P, Bankwitz D, Brown RJP, Todt D, Doepke M, Khan AG, Schulze K, Law J, Logan M, Hockman D, Wong JAJ, Dold L, Gonzalez-Motos V, Spengler U, Viejo-Borbolla A, Ströh LJ, Krey T, Tarr AW, Steinmann E, Manns MP, Klein F, Guzman CA, Marcotrigiano J, Houghton M, Pietschmann T.

J Hepatol. 2019 Apr;70(4):593-602. doi: 10.1016/j.jhep.2018.11.003. Epub 2018 Nov 13.

PMID:
30439392
9.

Sludge blanket anaerobic baffled reactor for source-separated blackwater treatment.

Moges ME, Todt D, Janka E, Heistad A, Bakke R.

Water Sci Technol. 2018 Nov;78(5-6):1249-1259. doi: 10.2166/wst.2018.411.

PMID:
30388081
10.

Hepatitis E virus treatment and ribavirin therapy: viral mechanisms of nonresponse.

Todt D, Meister TL, Steinmann E.

Curr Opin Virol. 2018 Oct;32:80-87. doi: 10.1016/j.coviro.2018.10.001. Epub 2018 Oct 29. Review.

11.

High Environmental Stability of Hepatitis B Virus and Inactivation Requirements for Chemical Biocides.

Than TT, Jo E, Todt D, Nguyen PH, Steinmann J, Steinmann E, Windisch MP.

J Infect Dis. 2019 Mar 15;219(7):1044-1048. doi: 10.1093/infdis/jiy620.

12.

Clinical Outcome and Viral Genome Variability of Hepatitis B Virus-Induced Acute Liver Failure.

Anastasiou OE, Widera M, Westhaus S, Timmer L, Korth J, Gerken G, Canbay A, Todt D, Steinmann E, Schwarz T, Timm J, Verheyen J, Ciesek S.

Hepatology. 2019 Mar;69(3):993-1003. doi: 10.1002/hep.30279. Epub 2019 Feb 11.

PMID:
30229977
13.

The Small-Compound Inhibitor K22 Displays Broad Antiviral Activity against Different Members of the Family Flaviviridae and Offers Potential as a Panviral Inhibitor.

García-Nicolás O, V'kovski P, Vielle NJ, Ebert N, Züst R, Portmann J, Stalder H, Gaschen V, Vieyres G, Stoffel M, Schweizer M, Summerfield A, Engler O, Pietschmann T, Todt D, Alves MP, Thiel V, Pfaender S.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e01206-18. doi: 10.1128/AAC.01206-18. Print 2018 Nov.

14.

First detection and frequent occurrence of Equine Hepacivirus in horses on the African continent.

Badenhorst M, Tegtmeyer B, Todt D, Guthrie A, Feige K, Campe A, Steinmann E, Cavalleri JMV.

Vet Microbiol. 2018 Sep;223:51-58. doi: 10.1016/j.vetmic.2018.07.015. Epub 2018 Jul 21.

PMID:
30173752
15.

Exophiala dermatitidis isolates from various sources: using alternative invertebrate host organisms (Caenorhabditis elegans and Galleria mellonella) to determine virulence.

Olsowski M, Hoffmann F, Hain A, Kirchhoff L, Theegarten D, Todt D, Steinmann E, Buer J, Rath PM, Steinmann J.

Sci Rep. 2018 Aug 24;8(1):12747. doi: 10.1038/s41598-018-30909-5.

16.

Interferon-beta expression and type I interferon receptor signaling of hepatocytes prevent hepatic necrosis and virus dissemination in Coxsackievirus B3-infected mice.

Koestner W, Spanier J, Klause T, Tegtmeyer PK, Becker J, Herder V, Borst K, Todt D, Lienenklaus S, Gerhauser I, Detje CN, Geffers R, Langereis MA, Vondran FWR, Yuan Q, van Kuppeveld FJM, Ott M, Staeheli P, Steinmann E, Baumgärtner W, Wacker F, Kalinke U.

PLoS Pathog. 2018 Aug 3;14(8):e1007235. doi: 10.1371/journal.ppat.1007235. eCollection 2018 Aug.

17.

The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo.

Todt D, Moeller N, Praditya D, Kinast V, Friesland M, Engelmann M, Verhoye L, Sayed IM, Behrendt P, Dao Thi VL, Meuleman P, Steinmann E.

Antiviral Res. 2018 Sep;157:151-158. doi: 10.1016/j.antiviral.2018.07.010. Epub 2018 Jul 20.

18.

Susceptibility of Chikungunya Virus to Inactivation by Heat and Commercially and World Health Organization-Recommended Biocides.

Franz S, Friesland M, Passos V, Todt D, Simmons G, Goffinet C, Steinmann E.

J Infect Dis. 2018 Sep 22;218(9):1507-1510. doi: 10.1093/infdis/jiy359.

19.

Environmental Stability and Infectivity of Hepatitis C Virus (HCV) in Different Human Body Fluids.

Pfaender S, Helfritz FA, Siddharta A, Todt D, Behrendt P, Heyden J, Riebesehl N, Willmann W, Steinmann J, Münch J, Ciesek S, Steinmann E.

Front Microbiol. 2018 Mar 27;9:504. doi: 10.3389/fmicb.2018.00504. eCollection 2018.

20.

Hepatitis E virus replication and interferon responses in human placental cells.

Knegendorf L, Drave SA, Dao Thi VL, Debing Y, Brown RJP, Vondran FWR, Resner K, Friesland M, Khera T, Engelmann M, Bremer B, Wedemeyer H, Behrendt P, Neyts J, Pietschmann T, Todt D, Steinmann E.

Hepatol Commun. 2018 Jan 8;2(2):173-187. doi: 10.1002/hep4.1138. eCollection 2018 Feb.

21.

Virucidal efficacy of peracetic acid for instrument disinfection.

Becker B, Brill FHH, Todt D, Steinmann E, Lenz J, Paulmann D, Bischoff B, Steinmann J.

Antimicrob Resist Infect Control. 2017 Nov 10;6:114. doi: 10.1186/s13756-017-0271-3. eCollection 2017.

22.

Hepatitis C Virus Strain-Dependent Usage of Apolipoprotein E Modulates Assembly Efficiency and Specific Infectivity of Secreted Virions.

Weller R, Hueging K, Brown RJP, Todt D, Joecks S, Vondran FWR, Pietschmann T.

J Virol. 2017 Aug 24;91(18). pii: e00422-17. doi: 10.1128/JVI.00422-17. Print 2017 Sep 15.

23.

Virucidal Activity of World Health Organization-Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging Coronaviruses.

Siddharta A, Pfaender S, Vielle NJ, Dijkman R, Friesland M, Becker B, Yang J, Engelmann M, Todt D, Windisch MP, Brill FH, Steinmann J, Steinmann J, Becker S, Alves MP, Pietschmann T, Eickmann M, Thiel V, Steinmann E.

J Infect Dis. 2017 Mar 15;215(6):902-906. doi: 10.1093/infdis/jix046.

24.

Immune protection against reinfection with nonprimate hepacivirus.

Pfaender S, Walter S, Grabski E, Todt D, Bruening J, Romero-Brey I, Gather T, Brown RJ, Hahn K, Puff C, Pfankuche VM, Hansmann F, Postel A, Becher P, Thiel V, Kalinke U, Wagner B, Bartenschlager R, Baumgärtner W, Feige K, Pietschmann T, Cavalleri JM, Steinmann E.

Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):E2430-E2439. doi: 10.1073/pnas.1619380114. Epub 2017 Mar 8.

25.

Successful retreatment of a patient with chronic hepatitis C genotype 2k/1b virus with ombitasvir/paritaprevir/ritonavir plus dasabuvir.

Todt D, Schlevogt B, Deterding K, Grundhoff A, Manns MP, Wedemeyer H, Fischer N, Cornberg M, Steinmann E.

J Antimicrob Chemother. 2017 May 1;72(5):1541-1543. doi: 10.1093/jac/dkw572. No abstract available.

PMID:
28100444
26.

Tracking HCV protease population diversity during transmission and susceptibility of founder populations to antiviral therapy.

Khera T, Todt D, Vercauteren K, McClure CP, Verhoye L, Farhoudi A, Bhuju S, Geffers R, Baumert TF, Steinmann E, Meuleman P, Pietschmann T, Brown RJ.

Antiviral Res. 2017 Mar;139:129-137. doi: 10.1016/j.antiviral.2017.01.001. Epub 2017 Jan 3.

27.

Inactivation of HCV and HIV by microwave: a novel approach for prevention of virus transmission among people who inject drugs.

Siddharta A, Pfaender S, Malassa A, Doerrbecker J, Anggakusuma, Engelmann M, Nugraha B, Steinmann J, Todt D, Vondran FW, Mateu-Gelabert P, Goffinet C, Steinmann E.

Sci Rep. 2016 Nov 18;6:36619. doi: 10.1038/srep36619.

28.

Exacerbation of hepatitis E virus infection during anti-TNFα treatment.

Behrendt P, Lüth S, Dammermann W, Drave S, Brown RJ, Todt D, Schnoor U, Steinmann E, Wedemeyer H, Pischke S, Iking-Konert C.

Joint Bone Spine. 2017 Mar;84(2):217-219. doi: 10.1016/j.jbspin.2016.09.017. Epub 2016 Nov 8.

PMID:
27836355
29.

Differential Infection Patterns and Recent Evolutionary Origins of Equine Hepaciviruses in Donkeys.

Walter S, Rasche A, Moreira-Soto A, Pfaender S, Bletsa M, Corman VM, Aguilar-Setien A, García-Lacy F, Hans A, Todt D, Schuler G, Shnaiderman-Torban A, Steinman A, Roncoroni C, Veneziano V, Rusenova N, Sandev N, Rusenov A, Zapryanova D, García-Bocanegra I, Jores J, Carluccio A, Veronesi MC, Cavalleri JMV, Drosten C, Lemey P, Steinmann E, Drexler JF.

J Virol. 2016 Dec 16;91(1). pii: e01711-16. doi: 10.1128/JVI.01711-16. Print 2017 Jan 1.

30.

Mutagenic Effects of Ribavirin on Hepatitis E Virus-Viral Extinction versus Selection of Fitness-Enhancing Mutations.

Todt D, Walter S, Brown RJ, Steinmann E.

Viruses. 2016 Oct 13;8(10). pii: E283. Review.

31.

Emergence of linezolid- and vancomycin-resistant Enterococcus faecium in a department for hematologic stem cell transplantation.

Krull M, Klare I, Ross B, Trenschel R, Beelen DW, Todt D, Steinmann E, Buer J, Rath PM, Steinmann J.

Antimicrob Resist Infect Control. 2016 Sep 22;5:31. doi: 10.1186/s13756-016-0131-6. eCollection 2016.

32.

Acute and chronic infections with nonprimate hepacivirus in young horses.

Gather T, Walter S, Pfaender S, Todt D, Feige K, Steinmann E, Cavalleri JM.

Vet Res. 2016 Sep 22;47(1):97.

33.

Hepacivirus NS3/4A Proteases Interfere with MAVS Signaling in both Their Cognate Animal Hosts and Humans: Implications for Zoonotic Transmission.

Anggakusuma, Brown RJP, Banda DH, Todt D, Vieyres G, Steinmann E, Pietschmann T.

J Virol. 2016 Nov 14;90(23):10670-10681. doi: 10.1128/JVI.01634-16. Print 2016 Dec 1.

34.

Apolipoprotein E polymorphisms and their protective effect on hepatitis E virus replication.

Weller R, Todt D, Engelmann M, Friesland M, Wedemeyer H, Pietschmann T, Steinmann E.

Hepatology. 2016 Dec;64(6):2274-2276. doi: 10.1002/hep.28788. Epub 2016 Sep 30. No abstract available.

PMID:
27541341
35.

Vertical transmission of hepatitis C virus-like non-primate hepacivirus in horses.

Gather T, Walter S, Todt D, Pfaender S, Brown RJ, Postel A, Becher P, Moritz A, Hansmann F, Baumgaertner W, Feige K, Steinmann E, Cavalleri JV.

J Gen Virol. 2016 Oct;97(10):2540-2551. doi: 10.1099/jgv.0.000561. Epub 2016 Jul 26.

PMID:
27461949
36.

Hepatitis E Virus (HEV) ORF2 Antigen Levels Differentiate Between Acute and Chronic HEV Infection.

Behrendt P, Bremer B, Todt D, Brown RJ, Heim A, Manns MP, Steinmann E, Wedemeyer H.

J Infect Dis. 2016 Aug 1;214(3):361-8. doi: 10.1093/infdis/jiw161. Epub 2016 May 27.

PMID:
27234418
37.

In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome.

Todt D, Gisa A, Radonic A, Nitsche A, Behrendt P, Suneetha PV, Pischke S, Bremer B, Brown RJ, Manns MP, Cornberg M, Bock CT, Steinmann E, Wedemeyer H.

Gut. 2016 Oct;65(10):1733-43. doi: 10.1136/gutjnl-2015-311000. Epub 2016 May 24.

38.

Extra-hepatic replication and infection of hepatitis E virus in neuronal-derived cells.

Drave SA, Debing Y, Walter S, Todt D, Engelmann M, Friesland M, Wedemeyer H, Neyts J, Behrendt P, Steinmann E.

J Viral Hepat. 2016 Jul;23(7):512-21. doi: 10.1111/jvh.12515. Epub 2016 Feb 19.

PMID:
26891712
39.

Development and virucidal activity of a novel alcohol-based hand disinfectant supplemented with urea and citric acid.

Ionidis G, Hübscher J, Jack T, Becker B, Bischoff B, Todt D, Hodasa V, Brill FH, Steinmann E, Steinmann J.

BMC Infect Dis. 2016 Feb 11;16:77. doi: 10.1186/s12879-016-1410-9.

40.

Antiviral Activities of Different Interferon Types and Subtypes against Hepatitis E Virus Replication.

Todt D, François C, Anggakusuma, Behrendt P, Engelmann M, Knegendorf L, Vieyres G, Wedemeyer H, Hartmann R, Pietschmann T, Duverlie G, Steinmann E.

Antimicrob Agents Chemother. 2016 Mar 25;60(4):2132-9. doi: 10.1128/AAC.02427-15. Print 2016 Apr.

41.

Impact of organic polyelectrolytes on coagulation of source-separated black water.

Kozminykh P, Heistad A, Ratnaweera HC, Todt D.

Environ Technol. 2016;37(14):1723-32. doi: 10.1080/09593330.2015.1130175. Epub 2016 Jan 29.

PMID:
26672384
42.

Several Human Liver Cell Expressed Apolipoproteins Complement HCV Virus Production with Varying Efficacy Conferring Differential Specific Infectivity to Released Viruses.

Hueging K, Weller R, Doepke M, Vieyres G, Todt D, Wölk B, Vondran FW, Geffers R, Lauber C, Kaderali L, Penin F, Pietschmann T.

PLoS One. 2015 Jul 30;10(7):e0134529. doi: 10.1371/journal.pone.0134529. eCollection 2015.

43.

Assessment of cross-species transmission of hepatitis C virus-related non-primate hepacivirus in a population of humans at high risk of exposure.

Pfaender S, Walter S, Todt D, Behrendt P, Doerrbecker J, Wölk B, Engelmann M, Gravemann U, Seltsam A, Steinmann J, Burbelo PD, Klawonn F, Feige K, Pietschmann T, Cavalleri JM, Steinmann E.

J Gen Virol. 2015 Sep;96(9):2636-42. doi: 10.1099/vir.0.000208. Epub 2015 Jun 3.

44.

Interferon-inducible cholesterol-25-hydroxylase restricts hepatitis C virus replication through blockage of membranous web formation.

Anggakusuma, Romero-Brey I, Berger C, Colpitts CC, Boldanova T, Engelmann M, Todt D, Perin PM, Behrendt P, Vondran FW, Xu S, Goffinet C, Schang LM, Heim MH, Bartenschlager R, Pietschmann T, Steinmann E.

Hepatology. 2015 Sep;62(3):702-14. doi: 10.1002/hep.27913. Epub 2015 Jul 28.

PMID:
25999047
45.

Particle removal in a novel sequential mechanical filter system loaded with blackwater.

Todt D, Jenssen PD.

Water Sci Technol. 2015;71(9):1407-13. doi: 10.2166/wst.2015.114.

PMID:
25945859
46.

Mechanisms of methods for hepatitis C virus inactivation.

Pfaender S, Brinkmann J, Todt D, Riebesehl N, Steinmann J, Steinmann J, Pietschmann T, Steinmann E.

Appl Environ Microbiol. 2015 Mar;81(5):1616-21. doi: 10.1128/AEM.03580-14. Epub 2014 Dec 19.

47.

Load and distribution of organic matter and nutrients in a separated household wastewater stream.

Todt D, Heistad A, Jenssen PD.

Environ Technol. 2015 May-Jun;36(9-12):1584-93. doi: 10.1080/09593330.2014.997300. Epub 2015 Jan 12.

PMID:
25495947
48.

Removal of particles in organic filters in experimental treatment systems for domestic wastewater and black water.

Todt D, Jenssen PD, Klemenčič AK, Oarga A, Bulc TG.

J Environ Sci Health A Tox Hazard Subst Environ Eng. 2014;49(8):948-54. doi: 10.1080/10934529.2014.893795.

PMID:
24766596
49.

Memory-dependent adjustment of vocal response latencies in a territorial songbird.

Geberzahn N, Hultsch H, Todt D.

J Physiol Paris. 2013 Jun;107(3):203-9. doi: 10.1016/j.jphysparis.2012.05.004. Epub 2012 Jun 4.

PMID:
22677884
50.

Do Barbary macaques 'comment' on what they see? A first report on vocalizations accompanying interactions of third parties.

Brumm H, Kipper S, Riechelmann C, Todt D.

Primates. 2005 Apr;46(2):141-4. Epub 2004 Aug 14.

PMID:
15316830

Supplemental Content

Support Center